QLS1128

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QLS1128, covering 2023-01-19 to 2023-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 [Phase 3]